Citadel Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-798,500
| Closed | -$14M | – | 7715 |
|
|
2021
Q3 | $14M | Sell |
798,500
-3,368,259
| -81% | -$59.1M | ﹤0.01% | 1147 |
|
|
2021
Q2 | $40.4M | Buy |
4,166,759
+654,608
| +19% | +$6.35M | 0.01% | 589 |
|
|
2021
Q1 | $37.7M | Sell |
3,512,151
-590,971
| -14% | -$6.35M | 0.01% | 604 |
|
|
2020
Q4 | $60.4M | Buy |
4,103,122
+359,710
| +10% | +$5.29M | 0.02% | 362 |
|
|
2020
Q3 | $53.2M | Buy |
3,743,412
+520,948
| +16% | +$7.4M | 0.02% | 377 |
|
|
2020
Q2 | $26.1M | Sell |
3,222,464
-220,770
| -6% | -$1.79M | 0.01% | 645 |
|
|
2020
Q1 | $13.9M | Buy |
+3,443,234
| New | +$13.9M | 0.01% | 811 |
|
|
2019
Q4 | – | Sell |
-34,899
| Closed | -$11K | – | 5330 |
|
|
2019
Q3 | $11K | Buy |
+34,899
| New | +$11K | ﹤0.01% | 4579 |
|
|
2019
Q1 | – | Sell |
-23,229
| Closed | -$40K | – | 5233 |
|
|
2018
Q4 | $40K | Buy |
+23,229
| New | +$40K | ﹤0.01% | 4137 |
|
|
2018
Q1 | – | Sell |
-24,622
| Closed | -$180K | – | 4566 |
|
|
2017
Q4 | $180K | Buy |
+24,622
| New | +$180K | ﹤0.01% | 3416 |
|